V
Vir Biotechnology, Inc.
VIRHealth Care· San Francisco, CA, US
LAYOFFS TRACKED
1
LAST EVENT
Sep 30, 2024
MARKET CAP
$1.87B
as of Aug 26, 2026
EMPLOYEES
900
Vir Biotechnology, Inc. is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The company develops antibody-based and other biologic therapies targeting pathogens such as hepatitis B virus, influenza, and coronaviruses.
Layoff timeline
1 EVENTStories from here
No one has shared a story from Vir Biotechnology yet. Went through a layoff here? Your experience helps others feel less alone.
Share your story →Get alerts for Vir Biotechnology
We'll email you the moment a new layoff is reported here.